{
      "rev_number": 1,
      "datestamp": "2026-05-26 16:27:15",
      "publisher": "Research Science and Innovation House",
      "keywords": "Homiladorlik, farmakoterapiya, teratogen ta\u2019sir, dori xavfsizligi, risk va foyda tahlili, FDA tasnifi, klinik farmakologiya",
      "sword_depositor": 1,
      "dir": "disk0/00/09/06/62",
      "lastmod": "2026-05-26 16:27:15",
      "publication": "ACUMEN: INTERNATIONAL JOURNAL OF MULTIDISCIPLINARY RESEARCH",
      "eprint_status": "archive",
      "status_changed": "2026-05-26 16:27:15",
      "title": "HOMILADORLIKDA DORI VOSITALARINI QO'LLASH: XAVF VA FOYDA TAHLILI",
      "abstract": "Homiladorlik davrida dori vositalarini qo\u2018llash klinik farmakologiyaning eng murakkab va mas\u2019uliyatli yo\u2018nalishlaridan biri hisoblanadi, chunki farmakoterapiya nafaqat ona organizmiga, balki homila rivojlanishiga ham bevosita ta\u2019sir ko\u2018rsatadi. Ushbu maqolada homiladorlikda qo\u2018llaniladigan dori vositalarining xavf va foyda nisbati, teratogen ta\u2019sir mexanizmlari hamda FDA va xalqaro tasniflash tizimlari asosida dori xavfsizligini baholash yoritiladi. Shuningdek, antibiotiklar, antihipertenzivlar, analgetiklar va vitamin preparatlari misolida klinik amaliyotda eng ko\u2018p uchraydigan holatlar tahlil qilinadi. Tadqiqot natijalari homiladorlikda farmakoterapiyani individual yondashuv asosida tanlash zarurligini ko\u2018rsatadi va xavfsiz davolash strategiyalarini ishlab chiqishga xizmat qiladi.",
      "creators": [
        {
          "name": {
            "family": "Zarnigor",
            "lineage": null,
            "given": "Ochilova",
            "honourific": null
          }
        },
        {
          "name": {
            "given": "Jo'r\u0430ev Zohidjon",
            "honourific": null,
            "lineage": null,
            "family": "\u0410shurovich"
          }
        }
      ],
      "eprintid": 90662,
      "date": "2026-05-10",
      "uri": "https://arxiv.universalpublishings.com/id/eprint/90662",
      "type": "article",
      "full_text_status": "none",
      "id_number": "oai:ojs.pkp.sfu.ca:article/18412",
      "userid": 1,
      "official_url": "https://universalpublishings.com/index.php/aijmr/article/view/18412",
      "subjects": [
        "Homiladorlik, farmakoterapiya, teratogen ta\u2019sir, dori xavfsizligi, risk va foyda tahlili, FDA tasnifi, klinik farmakologiya"
      ],
      "ispublished": "pub",
      "date_type": "published",
      "metadata_visibility": "show",
      "note": "Imported from Universal Publishings (OAI id oai:ojs.pkp.sfu.ca:article/18412)"
    }